Market Overview:Rabies antiserum is a type of antivenom produced from the hyperimmunized horse serum or equine antirabies immunoglobulin. It acts by neutralizing the rabies virus and preventing the development of clinical rabies in humans. Rabies antiserum is administered as a post-exposure prophylaxis, mainly for category III exposure as recommended by the World Health Organization. Some key...
The global Rabies Antiserum Market is estimated to be valued at US$ 1.20 billion in 2022 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Rabies Antiserum Market refers to the market for antiserum used for the prevention and treatment of rabies. Rabies is a deadly viral disease...
The global Rabies Antiserum Market is estimated to be valued at US$ 1.20 billion in 2022 and is expected to exhibit a CAGR of 3.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Rabies Antiserum Market refers to the market for antiserum used for the prevention and treatment of rabies. Rabies is a deadly viral disease...